Gross Revenue (YTD)11.2%
$14.2M
vs Target $12.8M
EBITDA Margin2.5%
24.5%
Target: 22%
Client Retention1.8%
88.2%
Target: 90%
Pipeline Value8.4%
$4.8M
Weighted Forecast
Financial Performance vs Forecast
Actual Rev
Target
OpEx
Revenue by Service Line
45%Retainer
Key Account Health Matrix
| Client Name | Region | Ann. Revenue | Health Score | Status | Risk Profile |
|---|---|---|---|---|---|
| Nike Global | NA | $4.2M | Growth | Low | |
| Unilever | EMEA | $2.8M | Stable | Low | |
| Tesla Motors | NA | $1.5M | At Risk | High | |
| Samsung | APAC | $3.1M | Growth | Low | |
| Novartis | EMEA | $0.9M | Churn | Med |
Strategic Risk Register
Legal Risk
HighGDPR Compliance Audit pending for EU Division.
Owner: Legal
Talent Risk
MedHead of Strategy role vacant > 60 days.
Owner: HR
Client Risk
CriticalTesla contract renewal negotiation stalled.
Owner: Sales
2 Critical Risks require Board Attention.